Add like
Add dislike
Add to saved papers

High frequency of CYP337B3 gene associated with control failures of Helicoverpa armigera with pyrethroid insecticides in Brazil.

Control failures with the use of pyrethroid insecticides have been reported frequently for populations of Helicoverpa armigera (Hübner) in Brazil, since its detection in 2013. Here, we confirmed and investigated the metabolic mechanisms of pyrethroid resistance in H. armigera populations from Brazil. Mortality of H. armigera populations was lower than 50% at the highest dose (10μg a.i./3rd instar larva) of the pyrethroids deltamethrin and fenvalerate in dose-response bioassays. Very low mortality (10 to 40%) was obtained at a diagnostic dose of 10μg a.i./larva for each pyrethroid in H. armigera populations collected from different agricultural regions in Brazil, from 2013 to 2016. In synergist bioassays, when larvae were treated with PBO synergist, the mortality of all populations tested was 100%. The frequency of the cytochrome P450 CYP337B3 gene was above 0.95 in all populations of H. armigera. We found only fourteen heterozygous H. armigera out of 497 individuals tested for this gene subfamily. Our results indicated that H. armigera populations from Brazil have different degrees of susceptibility to deltamethrin and fenvalerate, but all populations can be considered tolerant to pyrethroid insecticides. The chimeric P450 CYP337B3 enzyme is one of the main mechanisms of pyrethroid resistance in Brazilian H. armigera populations.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app